The targeting RNA-seq is used to analyze the naturally occurring splicing events of eight BC and/or ovarian cancer susceptibility genes (BRCA1, BRCA2, RAD51C, Rad51d, PTEN, STK11, CDH1, TP53). This evidence concerns the gene BRCA1 and ovarian cancer.